Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
0.295
-0.020 (-6.23%)
At close: Dec 20, 2024, 4:00 PM
0.310
+0.015 (5.08%)
After-hours: Dec 20, 2024, 6:58 PM EST
Revelation Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Market Capitalization | 1 | 3 | 4 | 67 | 93 |
Market Cap Growth | -67.76% | -29.53% | -93.31% | -28.41% | - |
Enterprise Value | -5 | -11 | -2 | 70 | - |
Last Close Price | 0.29 | 15.02 | 199.61 | 10710.02 | 10552.52 |
PB Ratio | 0.47 | 0.47 | 4.25 | -671.97 | 27.37 |
P/TBV Ratio | 0.52 | 0.47 | 4.25 | - | 31.04 |
Debt / Equity Ratio | - | - | - | -0.17 | - |
Quick Ratio | 1.61 | 2.15 | 1.18 | 0.60 | 3.72 |
Current Ratio | 1.64 | 2.18 | 1.22 | 0.89 | 3.82 |
Return on Equity (ROE) | -270.02% | -3.12% | -2272.77% | -723.81% | - |
Return on Assets (ROA) | -50.98% | -61.08% | -179.98% | -224.21% | - |
Return on Capital (ROIC) | -92.97% | -140.53% | -1400.45% | -448.74% | - |
Earnings Yield | -1225.30% | -3.81% | -242.05% | -17.93% | -4.07% |
FCF Yield | -1311.99% | -231.09% | -250.76% | -16.79% | -2.28% |
Buyback Yield / Dilution | -525.77% | -215.00% | - | - | - |
Total Shareholder Return | -525.77% | -215.00% | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.